Märit Wallander

835 total citations
15 papers, 614 citations indexed

About

Märit Wallander is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Märit Wallander has authored 15 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Märit Wallander's work include Hyperglycemia and glycemic control in critically ill and hospitalized patients (6 papers), Bone health and osteoporosis research (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Märit Wallander is often cited by papers focused on Hyperglycemia and glycemic control in critically ill and hospitalized patients (6 papers), Bone health and osteoporosis research (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Märit Wallander collaborates with scholars based in Sweden, Australia and United Kingdom. Märit Wallander's co-authors include Mattias Lorentzon, Anna Norhammar, Kristian F. Axelsson, Dan Lundh, Anna G Nilsson, Lars Rydén, Klas Malmberg, Robert Rudäng, Anna Darelid and Lisa Johansson and has published in prestigious journals such as Diabetes Care, Journal of Bone and Mineral Research and Diabetologia.

In The Last Decade

Märit Wallander

15 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Märit Wallander Sweden 11 242 235 182 150 120 15 614
Inge I. de Liefde Netherlands 8 102 0.4× 346 1.5× 185 1.0× 198 1.3× 64 0.5× 11 607
Pedro Mezquita‐Raya Spain 16 354 1.5× 317 1.3× 258 1.4× 147 1.0× 23 0.2× 31 799
Myrto Eliades United States 6 222 0.9× 216 0.9× 125 0.7× 79 0.5× 54 0.5× 7 733
Yiting Xu China 17 246 1.0× 97 0.4× 221 1.2× 47 0.3× 123 1.0× 69 752
Judith Clearwater New Zealand 8 103 0.4× 283 1.2× 88 0.5× 103 0.7× 41 0.3× 9 635
Jawl‐Shan Hwang Taiwan 15 65 0.3× 235 1.0× 158 0.9× 150 1.0× 54 0.5× 37 635
Marcia J. Kayath Brazil 11 289 1.2× 103 0.4× 102 0.6× 65 0.4× 22 0.2× 24 560
Fen Lee Hew Malaysia 12 414 1.7× 193 0.8× 108 0.6× 44 0.3× 227 1.9× 25 785
Celina Franco Sweden 12 210 0.9× 94 0.4× 71 0.4× 145 1.0× 91 0.8× 12 688
Elizabeth Shane United States 6 47 0.2× 239 1.0× 86 0.5× 196 1.3× 56 0.5× 15 548

Countries citing papers authored by Märit Wallander

Since Specialization
Citations

This map shows the geographic impact of Märit Wallander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Märit Wallander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Märit Wallander more than expected).

Fields of papers citing papers by Märit Wallander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Märit Wallander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Märit Wallander. The network helps show where Märit Wallander may publish in the future.

Co-authorship network of co-authors of Märit Wallander

This figure shows the co-authorship network connecting the top 25 collaborators of Märit Wallander. A scholar is included among the top collaborators of Märit Wallander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Märit Wallander. Märit Wallander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Axelsson, Kristian F., Märit Wallander, Helena Johansson, et al.. (2022). Analysis of Comorbidities, Clinical Outcomes, and Parathyroidectomy in Adults With Primary Hyperparathyroidism. JAMA Network Open. 5(6). e2215396–e2215396. 23 indexed citations
2.
Wallander, Märit, Kristian F. Axelsson, Dan Lundh, & Mattias Lorentzon. (2018). Patients with prostate cancer and androgen deprivation therapy have increased risk of fractures—a study from the fractures and fall injuries in the elderly cohort (FRAILCO). Osteoporosis International. 30(1). 115–125. 42 indexed citations
3.
Axelsson, Kristian F., Märit Wallander, Helena Johansson, Dan Lundh, & Mattias Lorentzon. (2017). Hip fracture risk and safety with alendronate treatment in the oldest‐old. Journal of Internal Medicine. 282(6). 546–559. 37 indexed citations
4.
Wallander, Märit, Kristian F. Axelsson, Anna G Nilsson, Dan Lundh, & Mattias Lorentzon. (2016). Type 2 Diabetes and Risk of Hip Fractures and Non-Skeletal Fall Injuries in the Elderly: A Study From the Fractures and Fall Injuries in the Elderly Cohort (FRAILCO). Journal of Bone and Mineral Research. 32(3). 449–460. 87 indexed citations
5.
Nilsson, Anna G, Daniel Sundh, Lisa Johansson, et al.. (2016). Type 2 Diabetes Mellitus Is Associated With Better Bone Microarchitecture But Lower Bone Material Strength and Poorer Physical Function in Elderly Women: A Population-Based Study. Journal of Bone and Mineral Research. 32(5). 1062–1071. 169 indexed citations
6.
Hage, Camilla, Kerstin Brismar, Sergiu‐Bogdan Catrina, et al.. (2016). Copeptin, insulin-like growth factor binding protein-1 and sitagliptin: A report from the BEta-cell function in Glucose abnormalities and Acute Myocardial Infarction study. Diabetes and Vascular Disease Research. 13(4). 307–311. 5 indexed citations
7.
Wallander, Märit, Patrik Löfgren, & Mikael Rydén. (2015). [Skin lightening products are a part of everyday life in many parts of the world. Corticosteroids, hydroquinone and mercury are common ingredients].. PubMed. 112. 1 indexed citations
8.
Hage, Camilla, Lars Grip, Klas Malmberg, et al.. (2011). The predictive value of inflammatory activity and markers of the adipo-insular axis on restenosis in patients with type 2 diabetes. Diabetes and Vascular Disease Research. 8(2). 143–149. 3 indexed citations
9.
Wallander, Märit, Stefan Söderberg, & Anna Norhammar. (2008). Leptin—a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes. Diabetic Medicine. 25(8). 949–955. 24 indexed citations
10.
Anselmino, Matteo, Märit Wallander, Anna Norhammar, Linda Mellbin, & Lars Rydén. (2008). Implications of abnormal glucose metabolism in patients with coronary artery disease. Diabetes and Vascular Disease Research. 5(4). 285–290. 17 indexed citations
11.
Anselmino, Matteo, Linda Mellbin, Märit Wallander, & Lars Rydén. (2008). Early detection and integrated management of dysglycemia in cardiovascular disease: a key factor for decreasing the likelihood of future events.. PubMed. 9(1). 29–38. 6 indexed citations
12.
Wallander, Märit, Klas Malmberg, Anna Norhammar, Lars Rydén, & Åke Tenerz. (2007). Oral Glucose Tolerance Test: A Reliable Tool for Early Detection of Glucose Abnormalities in Patients With Acute Myocardial Infarction in Clinical Practice. Diabetes Care. 31(1). 36–38. 71 indexed citations
13.
Wallander, Märit, Anna Norhammar, Klas Malmberg, et al.. (2007). IGF Binding Protein 1 Predicts Cardiovascular Morbidity and Mortality in Patients With Acute Myocardial Infarction and Type 2 Diabetes. Diabetes Care. 30(9). 2343–2348. 48 indexed citations
14.
Wallander, Märit, Kerstin Brismar, John Öhrvik, Lars Rydén, & Anna Norhammar. (2006). Insulin-like growth factor I: a predictor of long-term glucose abnormalities in patients with acute myocardial infarction. Diabetologia. 49(10). 2247–2255. 21 indexed citations
15.
Wallander, Märit, Malgorzata Bartnik, Suad Efendić, et al.. (2005). Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study. Diabetologia. 48(11). 2229–2235. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inge I. de Liefde Breakdown of academic impact, for papers by Pedro Mezquita‐Raya Breakdown of academic impact, for papers by Myrto Eliades Breakdown of academic impact, for papers by Yiting Xu Breakdown of academic impact, for papers by Judith Clearwater Breakdown of academic impact, for papers by Jawl‐Shan Hwang Breakdown of academic impact, for papers by Marcia J. Kayath Breakdown of academic impact, for papers by Fen Lee Hew Breakdown of academic impact, for papers by Celina Franco Breakdown of academic impact, for papers by Elizabeth Shane
Rankless by CCL
2026